Ultrahuman Secures $35M Series B for Wearable Health Tech

Ultrahuman, a Bengaluru-based wearable tech firm that developed a smart ring, has secured $35 million in its Series B funding round to overhaul health tracking and wearable tech. This fundraising round was led by Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave, and, most significantly, Deepinder Goyal, Zomato’s Founder and CEO.

The recent funding was a mix of debt and equity. It takes Ultrahuman’s total funding to over $60 million, including its earlier Series A financing of $17.5 million led by Alpha Wave in 2021. This significant investment demonstrates investor confidence in Ultrahuman’s vision and ability to alter the health and wellness market through new wearable technologies.

Ultrahuman plans to use the new investment to expand its production capabilities and research into health tracking devices. The company’s product range includes cutting-edge items, including the Ring Air smart ring, the M1 Live glucose monitoring wearable, and the Blood Vision blood testing device. These gadgets allow users to track multiple health data easily, improving their overall well-being and fitness journey.

Market Presence and Growth Trajectory

Ultrahuman has made significant strides in the market, becoming the second-largest player in the smart ring segment while maintaining profitability over the past 12 months. The company’s strategic expansion into more than 150 retail outlets worldwide, including prestigious locations like London’s Selfridges, Changi Airport in Singapore, and the Virgin Megastore in Dubai, has contributed to its rapid growth and market penetration.

Despite its impressive growth, Ultrahuman has faced challenges typical of high-growth startups. The company reported a fourfold revenue increase from INR 7.38 crore in FY22 to INR 30 crore in FY23, indicating strong consumer demand for its products.

However, this growth was accompanied by a 20.3 percent rise in losses to INR 71 crore during the same period, reflecting the competitive landscape and investment in scaling operations.

“We broke even for some months last year, but now we’ve been generating cash, including last quarter. We typically operate at an EBITDA margin of 4-5 percent, and in about six months, we want to push the margin to about 10-15 percent,” said Mohit Kumar, CEO and co-founder of Ultrahuman.

The company operates at a gross margin of 60 percent, he added.

Legal Disputes and Competitive Landscape

Ultrahuman’s success has also attracted legal scrutiny. Finnish health wearable startup Oura filed a lawsuit alleging patent and copyright infringements. The lawsuit highlights the competitive intensity in the wearable smart ring market. It emphasizes the importance of intellectual property protection in the technology sector.

Looking ahead, Ultrahuman remains focused on driving innovation, enhancing user experience, and expanding its smart ring market presence globally. The wearables market continues to evolve, with competition from global players like Levels Health, Super Sapiens, and Oura. Ultrahuman’s commitment to delivering cutting-edge health tracking solutions positions it as a key player in shaping the future of wearable technology and personalized health monitoring.

Ultrahuman’s successful Series B funding round signifies a vote of confidence from investors. It highlights the company’s potential to redefine the health tech landscape with its innovative wearable devices and commitment to improving user wellness.

Stay ahead of the curve and follow IndiaTechDesk on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in India.